Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02YBP
|
||||
| Former ID |
DIB002209
|
||||
| Drug Name |
Mequitamium iodide
|
||||
| Synonyms |
LG-30435
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Asthma [ICD10:J45] | Discontinued in Phase 2 | [1] | ||
| Company |
Laboratorio Guidotti SpA
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C21H25IN2S
|
||||
| Canonical SMILES |
[C@H]1([C@@H]2CC[N@+](C1)(CC2)C)CN1c2ccccc2Sc2c1cccc2.[<br />I-]
|
||||
| CAS Number |
CAS 101396-42-3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Histamine H1 receptor | Target Info | Modulator | [2] | |
| KEGG Pathway | Calcium signaling pathway | ||||
| Neuroactive ligand-receptor interaction | |||||
| Inflammatory mediator regulation of TRP channels | |||||
| PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
| Reactome | Histamine receptors | ||||
| G alpha (q) signalling events | |||||
| WikiPathways | Monoamine GPCRs | ||||
| GPCRs, Class A Rhodopsin-like | |||||
| IL-4 Signaling Pathway | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| GPCR ligand binding | |||||
| GPCR downstream signaling | |||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000086) | ||||
| REF 2 | High-affinity binding of mequitamium iodide (LG 30435) to muscarinic and histamine H1 receptors. Eur J Pharmacol. 1990 Jul 17;182(3):413-20. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.